Age Dependency of Myocardial Triglyceride Content: A 3T High-Field 1H-MR Spectroscopy Study

Abstract

Purpose: The role of myocardial triglyceride (mTG) content in the aging human heart is not entirely understood. The aim of this study was to measure concentrations of mTG content from healthy volunteers and to determine the association between age, mTG content and systolic heart function. Furthermore, the technical stability of the 1H-magnetic resonance spectroscopy (1H-MRS) and the reliability of peak evaluation at 3?T were evaluated. Materials and Methods: The total study population of 47 healthy volunteers was divided into 4?age classes, according to the age of the subjects (1st cohort 20???29 years (yrs.), n?=?20; 2nd cohort 30???39 yrs., n?=?10; 3rd cohort 40???49 yrs., n?=?9; 4th cohort 50???60 yrs., n?=?8). Cardiac MRI and double triggered 1H-MRS of the myocardium were consecutively performed using a 3?T scanner. Each participant underwent spectroscopic measurements twice in the same investigation. Results: mTG content increases with age. The correlation of age and mTG is minimal (r?=?0.48; p?<?0.001). The following age-averaged mTG content values expressed as % of mTG signal compared to the water signal were determined for each cohort: 1st cohort 0.25?% (??0.17); 2nd cohort 0.48?% (??0.30); 3rd cohort 0.48?% (??0.18); 4th cohort 0.77?% (??0.70). There was no significant correlation (r?=?0.04; p?=?n.s.) between LV mass and mTG content in healthy volunteers. Within our cohorts, no effects of age or mTG content on systolic heart function were seen (r?=???0.01; p?=?n.s.). The intraclass correlation coefficient of spectroscopic measurements was high (r?=?0.965; p?<?0.001). Conclusion: Myocardial TG content increases with age. The normal age-dependent concentration ranges of myocardial lipid metabolites reported in this study may be helpful for the correction of acquired 1H-MRS data in patients when evaluating metabolic and cardiovascular diseases in future magnetic resonance spectroscopy studies. Key Points: ??1H-MRS enables noninvasive myocardial lipid determination ??Double triggered 1H-MRS of the heart at 3?T is a technically stable and reliable method ??Myocardial triglyceride content increases with age ??Myocardial triglyceride content is independent of LV mass and systolic function Citation Format: ??Petritsch B, Gassenmaier T, Kunz AS et?al. Age Dependency of Myocardial Triglyceride Content: A 3T High-Field 1H-MR Spectroscopy Study. Fortschr R?ntgenstr 2015; 187: 1016???1021

Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy

“…Results in the age-matched controls were in line with previous literature [38, 39]. To address diurnal changes of TG/W, subjects and patients were scanned during afternoon hours and with a prior fasting period of about 3 h [40].…”

Myocardial steatosis across the spectrum of human health and disease

“…Several studies suggest that myocardial triglyceride content increases with age (Petritsch et al., 2015 ; Sarma et al., 2013 ; van der Meer, Rijzewijk et al., 2008 ); however, the total sample size available to support this conclusion is relatively small, with very few reports measuring myocardial triglyceride content in individuals >65 years of age. Sex does not appear to influence myocardial triglyceride content in young, normal weight, healthy adults (Oneglia et al., 2023 ; Petritsch et al., 2016 ; Winhofer et al., 2012 ); however, the interaction between sex and metabolic dysfunction/disease has not been thoroughly investigated.…”

MRI in patients with pacemakers?First global consensus recommendationsfrom radiologists and cardiologists

“…In Germany and internationally the number of MRI examinations is increasing: 1,008,944 examinations were performed on patients receiving inpatient treatment in 2005 while 1,767,005 examinations were performed in 2013 (DRG hospitals). This development can be attributed to our aging population as well as to new indications for MRI including: Analyses of tissue composition and function, for example in the liver [3,4] and the heart [5,6]; multiparametric analyses of MR perfusion, e. g. in treated brain tumors [7]; new organs such as the lung [8]; dedicated examinations for intervention planning and operation monitoring [9 -11]; as well as MRI-guided interventions [12 -16].…”